Evidence map›Paper›PMID 32309535›Full record

ArticleDiscoveries (Craiova, Romania)2013

Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry.

Octavian Bucur, Alexandru Almasan, Barbara S Nikolajczyk, Garth L Nicolson, Jack Lawler, Victor E Velculescu, Sorin Draghici, Mircea Leabu, Dorina Avram, Ilie Bucur and 20 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Discoveries (Craiova, Romania), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Octavian BucurDepartment of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, USA.
Alexandru AlmasanDepartment of Cancer Biology, Lerner Research Institute & Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
Barbara S NikolajczykBoston University School of Medicine, Department of Microbiology, Boston, MA, USA.
Garth L NicolsonThe Institute for Molecular Medicine, Department of Molecular Pathology, Huntington Beach, CA, USA.
Jack LawlerDivision of Cancer Biology and Angiogenesis, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Victor E VelculescuSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287.
Sorin DraghiciIntelligent Systems and Bioinformatics Laboratory, Wayne State University, Detroit, MI, USA.
Mircea LeabuDepartment of Cellular and Molecular Medicine, University of Medicine and Pharmacy "Carol Davila" and "Victor Babes" National Institute of Pathology, Bucharest, Romania.
Dorina AvramCenter for Cell Biology and Cancer Research & Center for Immunology and Microbial Disease, Albany Medical College, Albany, NY, USA.
Ilie BucurApplied Systems, Craiova, Romania.
Enzo CalauttiDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
George A CalinDepartment of Experimental Therapeutics and Leukemia & Center for RNA Interference and Non-Coding RNAs, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Subhash C ChauhanDepartment of Pharmaceutical Sciences & Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee.
Mihai CiubotaruDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Stefan N Constantinescude Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
Dipak DattaCSIR-Central Drug Research Institute, Biochemistry Division, Lucknow, UP, India.
Dan G DudaSteele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA.
Mark T FriedmanDepartment of Pathology, St. Luke's-Roosevelt Hospital Center, Beth Israel Medical Center and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Paul J GalardyDepartment of Biochemistry and Molecular Biology & Division of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
Brent T HarrisDepartments of Pathology and Neurology, Georgetown University Medical Center, Washington, DC, USA.
Maite HuarteCenter for Applied Medical Research, University of Navarra, Pamplona, Spain.
Ahmad M KhalilDepartment of Genetics, Center for RNA Molecular Biology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Dario MarchettiDepartments of Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Liviu MovileanuDepartment of Physics, Structural Biology, Biochemistry, and Biophysics Program & Syracuse Biomaterials Institute, Syracuse University, Syracuse, NY, USA.
Roxana NatInstitute for Neuroscience, Medical University Innsbruck, Innsbruck, Austria.
Carmelo NuceraHuman Thyroid Cancers Preclinical and Translational Research Laboratory, Experimental Division of Cancer Biology and Angiogenesis, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Aurel Popa-WagnerDepartment of Psychiatry, Rostock University Medical School, Rostock, Germany.
Andreea L StancuDepartment of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, USA.
Shudong ZhuSchool of Biological Science and Technology, State Key Laboratory of Medical Genetics, Central South University, Changsha, China.
Elisa A LiehnInstitute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Discoveries is a new peer-reviewed, open access, online multidisciplinary and integrative journal publishing high impact reviews, experimental articles, perspective articles, and editorials from all areas related to medicine, biology, and chemistry, including but not limited to: Molecular and Cellular Biology, Biochemistry, Biophysics, Genomics, Proteomics, Biotechnology, Synthetic Biology, Bioengineering, Systems Biology, Bioinformatics, Translational Medicine, Medicine/ Clinical findings, Cognitive Science, Epidemiology, Global Medicine, Family Medicine, Organic/ Inorganic/ Physical Chemistry and Ethics in Science. Discoveries brings to the research community an outstanding editorial board that aims to address several of the innovations proposed above: there is no need to format the manuscript before submission, we have a rapid and efficient submission process, there is no need for a Cover Letter and we support the need for rules for validation of critical reagents, such as antibodies. Discoveries will aim to support high quality research on human subjects materials to provide relevance for non-human studies along with mechanistic insights into human biology and chemistry. We also aim to avoid requesting unnecessary experiments during the review process, without affecting the quality and conclusions of published manuscripts. In addition, we recognize the need of adopting the recommendations made by NCCD and other similar scientific guiding entities.

Indexed as

BiochemistryBioinformaticsBiophysicsbreakthrough researchClinical findingsClinical trialsEpidemiologyEthics in ScienceGenomicsGlobal MedicineInorganic ChemistryintegrativeinterdisciplinaryjournalMolecular and Cellular BiologymultidisciplinaryOrganic ChemistryPhysical ChemistryProteomics BiotechnologySynthetic BiologySystems BiologyTranslational Medicine

Identifiers

PMID32309535
PMCPMC6919543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.